Journal of Leukemia

Journal of Leukemia
Open Access

ISSN: 2329-6917

+44 1202068036

Citations Report

Citations Report - Journal of Leukemia [386 Articles]

The articles published in Journal of Leukemia have been cited 386 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Journal of Leukemia.

Кузьмина ТП, Давыдкин ИЛ, Осадчук АМ, Данилова ОЕ, Терешина ОВ, Шпигель АС, Степанова ТЮ, Наумова КВ. ХРОНИЧЕСКИЙ ЛИМФОЛЕЙКОЗ И КАРДИОТОКСИЧНОСТЬ: ПРОБЛЕМЫ И ПЕРСПЕКТИВЫ. Астраханский медицинский журнал. 2018;13(2).

Shukla P. Umbilical cord preservation-A Review. Biochem Mol Biol Lett. 2017;3(1):109.

Stadler N, Shang A, Bosch F, Briggs A, Goede V, Berthier A. LSHTM Research Online. Adv Ther. 2016;33:1814-30.

Kamini J. Why Imatinib is by Far the Best Drug to Treat Chronic Myeloid Leukemia. Biochem Mol Biol Lett. 2017;3(2):112.

Städler N, Shang A, Bosch F, Briggs A, Goede V, Berthier A, Renaudin C, Leblond V. A systematic review and network meta-analysis to evaluate the comparative efficacy of interventions for unfit patients with chronic lymphocytic leukemia. Advances in therapy. 2016 Oct 1;33(10):1814-30.

Edwards A, Nalla P, Premawardhana LD. A man with a short history of lower back pain. Bmj. 2016 Apr 7;353:i1722.

Singh N, Agrawal N, Sekhri R, Mehta A, Kumar D, Vishwakarma G, Ahmed R, Bhurani D. Light chain myeloma: A brief report from India. Indian Journal of Pathology and Microbiology. 2019 Jul 1;62(3):441.

Ríos-Tamayo R, Pérez MJ, Rodríguez DS, Chang-Chan YL. Epidemiology of Multiple Myeloma. InMultiple Myeloma 2018 Nov 5. IntechOpen.

Ortiz JV, Assunção BM, Crosbie MS, de Freitas FA. Cardiotoxicidade por Antraciclinas em Pacientes com Leucemia Aguda: Uma Revisão da Literatura. Revista Pleiade. 2017 Aug 25;11(21):5-16.

Ansari MS, Saraswat R, Sharma P, Alam MS. Effects of aliskiren on hemodynamic parametersin daunorubicin-induced acute cardiomyopathy in rats. Journal of Drug Delivery and Therapeutics. 2019 Jan 15;9(1):103-7.

Kamini J. Why Imatinib is by Far the Best Drug to Treat Chronic Myeloid Leukemia. Biochem Mol Biol Lett. 2017;3(2):112.

Huang XJ, Liu K, Ritchie D, Andersson B, Lu J, Hou J, de Fuente Burguera A, Wang J, Yeoh A, Yan C, Zhou D. Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China. Oncotarget. 2017 Jun 20;8(25):41620.

Ueno NT, Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G. International consensus on the clinical management of inflammatory breast cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. Journal of Cancer. 2018;9(8):1437.

Kamini J. Why Imatinib is by Far the Best Drug to Treat Chronic Myeloid Leukemia. Biochem Mol Biol Lett. 2017;3(2):112.

Mahdiraji WG. Electrical Energy Harvesting from Cooker’s Wasted Heat with Using Conduction Cooling. InMATEC Web of Conferences 2018 (Vol. 152, p. 02021). EDP Sciences.

Kawaguchi-Ihara N, Zhao Y, Nakamura S, Suzuki K, Zhang YI, Tohda S, Murohashi I. Chloroquine Inhibits Self-Renewal of Blast Progenitors Synergistically With Phytochemicals or Nonsteroidal Anti-inflammatory Drugs in Hematological Malignant Cell Lines. Anticancer research. 2019 Jan 1;39(1):87-98.

Shukla P. Umbilical cord preservation-A Review. Biochem Mol Biol Lett. 2017;3(1):109.

GV RR. Types of Cancer and Surgery in Rats (Rattus norvegicus). growth.;91:95.

Kamini J. Why Imatinib is by Far the Best Drug to Treat Chronic Myeloid Leukemia. Biochem Mol Biol Lett. 2017;3(2):112.

Shukla P. Umbilical cord preservation-A Review. Biochem Mol Biol Lett. 2017;3(1):109.

Relevant Topics

Top